These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37309823)

  • 1. MRI for Hepatitis B-Associated Intrahepatic Cholangiocarcinoma: A Multicenter Comparative Study.
    Sheng R; Wang H; Zhang Y; Sun W; Jin K; Dai Y; Zhang W; Zeng M; Zhou J
    J Magn Reson Imaging; 2024 Mar; 59(3):1093-1104. PubMed ID: 37309823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LI-RADS Category on MRI Is Associated With Recurrence of Intrahepatic Cholangiocarcinoma After Surgery: A Multicenter Study.
    Hwang JA; Lee S; Lee JE; Yoon J; Choi SY; Shin J
    J Magn Reson Imaging; 2023 Mar; 57(3):930-938. PubMed ID: 35833798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver Imaging and Data System (LI-RADS) Version 2018 and Other Imaging Features in Intrahepatic Cholangiocarcinoma in Chinese Adults with vs. without Chronic Hepatitis B Viral Infection.
    Liang YY; Shao S; Kuang S; Chen J; Zhou J; He B; Zhang L; Zhang Y; Fowler KJ; Wang J
    Can J Gastroenterol Hepatol; 2021; 2021():6639600. PubMed ID: 33748033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing the clinicopathological characteristics of combined hepatocellular-cholangiocarcinoma with those of other primary liver cancers by use of the updated World Health Organization classification.
    Yen CC; Yen CJ; Shan YS; Lin YJ; Liu IT; Huang HY; Yeh MM; Chan SH; Tsai HW
    Histopathology; 2021 Oct; 79(4):556-572. PubMed ID: 33837585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multi-center diagnostic system for intrahepatic mass-forming cholangiocarcinoma based on preoperative MRI and clinical features.
    Sheng R; Zhang Y; Wang H; Zhang W; Jin K; Sun W; Dai Y; Zhou J; Zeng M
    Eur Radiol; 2024 Jan; 34(1):548-559. PubMed ID: 37552257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative subcategorization based on magnetic resonance imaging in intrahepatic cholangiocarcinoma.
    Xiao Y; Zhou C; Ni X; Huang P; Wu F; Yang C; Zeng M
    Cancer Imaging; 2023 Feb; 23(1):15. PubMed ID: 36782276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computed Tomography Radiomics to Differentiate Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma.
    Mahmoudi S; Bernatz S; Ackermann J; Koch V; Dos Santos DP; Grünewald LD; Yel I; Martin SS; Scholtz JE; Stehle A; Walter D; Zeuzem S; Wild PJ; Vogl TJ; Kinzler MN
    Clin Oncol (R Coll Radiol); 2023 May; 35(5):e312-e318. PubMed ID: 36804153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apparent Diffusion Coefficient MRI Shows Association With Early Progression of Unresectable Intrahepatic Cholangiocarcinoma With Combined Targeted-Immunotherapy.
    Sheng R; Sun W; Huang X; Jin K; Gao S; Zeng M; Wu D; Shi G
    J Magn Reson Imaging; 2023 Jan; 57(1):275-284. PubMed ID: 35488518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Very early" intrahepatic cholangiocarcinoma (≤ 2.0 cm): MRI manifestation and prognostic potential.
    Sheng R; Zheng B; Zhang Y; Sun W; Yang C; Ding Y; Zhou J; Zeng M
    Clin Radiol; 2024 Aug; 79(8):608-617. PubMed ID: 38789332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A proposal of imaging classification of intrahepatic mass-forming cholangiocarcinoma into ductal and parenchymal types: clinicopathologic significance.
    Rhee H; Kim MJ; Park YN; An C
    Eur Radiol; 2019 Jun; 29(6):3111-3121. PubMed ID: 30560357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive characterization of viral integrations and genomic aberrations in HBV-infected intrahepatic cholangiocarcinomas.
    An J; Kim D; Oh B; Oh YJ; Song J; Park N; Kim HI; Kang HJ; Oh JH; Kim W; Lee E; Sung CO; Song GW; Kim DG; Yu E; Letouzé E; Zucman-Rossi J; Lee HC; Shim JH
    Hepatology; 2022 Apr; 75(4):997-1011. PubMed ID: 34478159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DCE-MRI based radiomics nomogram for preoperatively differentiating combined hepatocellular-cholangiocarcinoma from mass-forming intrahepatic cholangiocarcinoma.
    Zhou Y; Zhou G; Zhang J; Xu C; Zhu F; Xu P
    Eur Radiol; 2022 Jul; 32(7):5004-5015. PubMed ID: 35128572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic performance of LI-RADS version 2018 in differentiating hepatocellular carcinoma from other hepatic malignancies in patients with hepatitis B virus infection.
    Shao S; Liang Y; Kuang S; Chen J; Shan Q; Yang H; Zhang Y; Wang B; J Fowler K; Wang J; B Sirlin C
    Bosn J Basic Med Sci; 2020 Aug; 20(3):401-410. PubMed ID: 31999940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific prognostic factors in hepatitis B virus-related and non-hepatitis B virus-related intrahepatic cholangiocarcinoma after macroscopic curative resection.
    Huang J; Wang X; Zhu Y; Wang Z; Li J; Xu D; Wang S; Li TE; Lu L
    J Surg Oncol; 2019 Jan; 119(1):40-46. PubMed ID: 30480811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Clinical Features and Outcomes Between Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma in the United States.
    Lee YT; Wang JJ; Luu M; Noureddin M; Nissen NN; Patel TC; Roberts LR; Singal AG; Gores GJ; Yang JD
    Hepatology; 2021 Nov; 74(5):2622-2632. PubMed ID: 34114675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic Value of MRI Features in Dual-phenotype Hepatocellular Carcinoma: A Preliminary Study.
    Gu HX; Huang XS; Xu JX; Zhu P; Xu JF; Fan SF
    J Digit Imaging; 2023 Dec; 36(6):2554-2566. PubMed ID: 37578576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bile duct adenoma may be a precursor lesion of small duct type intrahepatic cholangiocarcinoma.
    Sasaki M; Sato Y; Nakanuma Y
    Histopathology; 2021 Jan; 78(2):310-320. PubMed ID: 33405289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual-energy CT based material decomposition to differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma.
    Mahmoudi S; Bernatz S; Althoff FC; Koch V; Grünewald LD; Scholtz JE; Walter D; Zeuzem S; Wild PJ; Vogl TJ; Kinzler MN
    Eur J Radiol; 2022 Nov; 156():110556. PubMed ID: 36270195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing Survival Outcomes of Patients With LI-RADS-M Hepatocellular Carcinomas and Intrahepatic Cholangiocarcinomas.
    Kierans AS; Lafata KJ; Ludwig DR; Burke LMB; Chernyak V; Fowler KJ; Fraum TJ; McGinty KA; McInnes MDF; Mendiratta-Lala M; Cunha GM; Allen BC; Hecht EM; Jaffe TA; Kalisz KR; Ranathunga DS; Wildman-Tobriner B; Cardona DM; Aslam A; Gaur S; Bashir MR
    J Magn Reson Imaging; 2023 Jan; 57(1):308-317. PubMed ID: 35512243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of microvascular invasion in combined hepatocellular-cholangiocarcinoma based on preoperative contrast-enhanced CT and clinical data.
    Zhang J; Dong W; Li Y; Fu J; Jia N
    Eur J Radiol; 2023 Jun; 163():110839. PubMed ID: 37121101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.